Immuron Ltd. Files August 2025 Report (6-K)
Ticker: IMRN · Form: 6-K · Filed: Aug 15, 2025 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Aug 15, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, regulatory-update
TL;DR
Immuron Ltd. filed its August 2025 6-K, confirming its foreign private issuer status and 20-F filing.
AI Summary
On August 15, 2025, Immuron Ltd. filed a Form 6-K, reporting its activities for August 2025. The filing indicates that the company is a foreign private issuer and is furnishing information to the SEC. It also confirms that Immuron Ltd. files annual reports under Form 20-F.
Why It Matters
This filing provides an update on Immuron Ltd.'s regulatory submissions and reporting status with the SEC, which is important for investors tracking the company's compliance and information dissemination.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer activities and does not contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- Immuron Ltd (company) — Registrant
- August 2025 (date) — Reporting period
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report form
FAQ
What is the primary purpose of this Form 6-K filing by Immuron Ltd.?
The primary purpose is to report on Immuron Ltd.'s activities for the month of August 2025 as a foreign private issuer.
Does Immuron Ltd. file annual reports under Form 20-F or Form 40-F?
Immuron Ltd. files annual reports under cover of Form 20-F.
Is Immuron Ltd. furnishing information under Rule 12g3-2(b)?
No, Immuron Ltd. is not furnishing information under Rule 12g3-2(b) for this filing.
What is the principal executive office address for Immuron Ltd.?
The principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
What is the Commission File Number for Immuron Ltd.?
The Commission File Number for Immuron Ltd. is 001-38104.
Filing Stats: 309 words · 1 min read · ~1 pages · Grade level 18.3 · Accepted 2025-08-15 07:20:57
Filing Documents
- ea0253464-6k_immuron.htm (6-K) — 13KB
- ea025346401ex99-2_immuron.htm (EX-99.2) — 35KB
- ex99-2_001.jpg (GRAPHIC) — 2KB
- 0001213900-25-077042.txt ( ) — 52KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of August 2025 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on August 15, 2025 titled: - Appendix 3G - A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.2 Notification regarding unquoted securities - IMC 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: August 15, 2025 By: /s/ Phillip Hains Phillip Hains Company Secretary 3